A pyrazole-containing selenium compound modulates neuroendocrine, oxidative stress, and behavioral responses to acute restraint stress in mice.
Animals
Anti-Anxiety Agents
/ administration & dosage
Anxiety
/ drug therapy
Behavior, Animal
/ drug effects
Corticosterone
/ blood
Hippocampus
/ drug effects
Hyperalgesia
/ drug therapy
Male
Mice
Neurosecretory Systems
/ drug effects
Nociception
/ drug effects
Oxidative Stress
/ drug effects
Prefrontal Cortex
/ drug effects
Pyrazoles
Restraint, Physical
Selenium
Stress, Psychological
/ drug therapy
Anxiety
Mice
Nociception
Pyrazole
Selenium
Stress
Journal
Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
received:
04
06
2020
revised:
13
08
2020
accepted:
17
08
2020
pubmed:
25
8
2020
medline:
10
11
2021
entrez:
25
8
2020
Statut:
ppublish
Résumé
The contribution of oxidative stress has been described in numerous studies as one of the main pathways involved in the pathophysiology of anxiety and its comorbidities, such as chronic pain. Therefore, in this study, we investigated the anxiolytic-like, antiallodynic, and anti-hyperalgesic effects of 3,5-dimethyl-1-phenyl-4-(phenylselanyl)-1H-pyrazole (SePy) in response to acute restraint stress (ARS) in mice through the modulation of oxidative stress and neuroendocrine responses. Mice were restrained for 2 h followed by SePy (1 or 10 mg/kg, intragastrically) treatment. Behavioral, and biochemical tests were performed after further 30 min. The treatment with SePy reversed (i) the decreased time spent and the number of entries in the open arms of the elevated plus-maze apparatus, (ii) the decreased time spent in the central zone of the open field test and the increased number of grooming, (iii) the increased number of marbles buried, (iv) the increased response frequency of Von Frey Hair stimulation, and (v) the decreased latency time to nociceptive response in the hot plate test stress induced by ARS. Biochemically, SePy reversed ARS-induced increased levels of plasma corticosterone, and reversed the ARS-induced alterations in the levels of reactive species, lipid peroxidation, and superoxide dismutase and catalase activities in the prefrontal cortices and hippocampi of mice. Moreover, a molecular docking approach suggested that SePy may interact with the active site of the glucocorticoid receptor. Altogether, these results indicate that SePy attenuated anxiolytic-like behavior, hyperalgesia, and mechanical allodynia while modulating oxidative stress and neuroendocrine responses in stressed mice.
Identifiants
pubmed: 32835778
pii: S0166-4328(20)30573-8
doi: 10.1016/j.bbr.2020.112874
pii:
doi:
Substances chimiques
Anti-Anxiety Agents
0
Pyrazoles
0
Selenium
H6241UJ22B
Corticosterone
W980KJ009P
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
112874Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.